| Duloxetine | Placebo | P |
---|---|---|---|
Values are expressed as n (%) | (N = 60) | (N = 61) | Â |
Total number of women with ≥ 1 TEAE | 48 (80) | 27 (44.3) | < .001 |
Constipation | 10 (16.7) | 0 (0.0) | .001 |
Dry mouth | 10 (16.7) | 2 (3.3) | .016 |
Nausea | 9 (15.0) | 0 (0.0) | .001 |
Somnolence | 9 (15.0) | 0 (0.0) | .001 |
Dizziness | 8 (13.3) | 6 (9.8) | .583 |
Fatigue | 5 (8.3) | 0 (0.0) | .027 |
Hyperhidrosis | 5 (8.3) | 0 (0.0) | .027 |
Cough | 4 (6.7) | 4 (6.6) | > .999 |
Decreased appetite | 4 (6.7) | 1 (1.6) | .207 |
Insomnia | 4 (6.7) | 2 (3.3) | .439 |
Asthenia | 3 (5.0) | 1 (1.6) | .365 |
Chest discomfort | 3 (5.0) | 3 (4.9) | > .999 |
Palpations | 3 (5.0) | 2 (3.3) | .680 |